Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients	Carcinoma, Ductal, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast disorder, breast ductal adenocarcinoma, breast mucinous carcinoma, breast neoplasm, carcinoma, epithelial neoplasm, inflammatory breast carcinoma, invasive tubular breast carcinoma, neoplasm, skin disorder	Active, not recruiting	Phase 2 / Phase 3	2023-08-29		NCT02221999

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
RenJi Hospital	264

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Armed Police Corps Hospital of Shanghai	Shanghai	China	1
Department of Breast Surgery, Obstetrics and Gynecology Hospital of Fudan University	Shanghai	China	1
Department of Medical Oncology, General Hospital of Ningxia Medical University	Yinchuan	China	1
Department of Thyroid and Breast Gland Surgery,Shenzhen Longgang Central Hospital	Shenzhen	China	1
Department of Thyroid and Breast Surgery, The Affiliated Hospital of Inner Mongolia Medical Collage	Hohhot	China	1
Handan Central Hospital	Handan	China	2
Shanghai Jiaotong University School of Medicine, Renji Hospital	Shanghai	China	3
The First Affiliated Hospital Of University Of South China	Hengyang	China	11
The second people's hospital of Kunshan city	Kunshan	China	1
Yueyang hospital of integrated traditional Chinese and Western medine	Shanghai	China	1
Zhongshan Hospital	Shanghai	China	20
Zhoushan hospital	Zhoushan	China	1